Similar to INa‐L, CaMKII levels are increased in pathological conditions predisposing to arrhythmias such as ischaemia and heart failure (Kirchhefer et al., 1999) as well as in atrial fibrillation (Neef et al., 2010). The gene discussed is CAMK2G; the disease is heart failure.